LAS VEGAS, NV - December 3, 2013 - Broadleaf Capital Partners, Inc. (OTC:BDLF) announced today that on November 29, 2013 the company completed its previously authorized acquisition of Sustained Release, Inc. The non-cash acquisition was accomplished with the newly designated BDLF Class A Preferred Shares.
Mike King, President of Broadleaf, stated: "Sustained Release brings us their Akina, Inc. technology contract for patented microparticle long-term release formulations. This will dynamically broaden Broadleaf's business activity and revenue base. We believe that this acquisition will enhance shareholder value."
Akina, Inc. is a research and development company known for developing unique methods for delivering medications. It was founded in 2001 by Kinam Park, Showalter Distinguished Professor of Biomedical Engineering and Professor of Pharmaceutics at Purdue University.
Akina Is a pioneer in the development of the long-term release microparticle formulations, also referenced as "Sustained Release" formulations, which have release durations ranging from one to eight months, and are designed to replace repeated daily, weekly or monthly administration of drugs for long-term care of diseases and disorders, thereby improving efficacy of the drug.
The Akina microparticles are programmable in release kinetics and ideal for release of active pharmaceutical ingredients for terms ranging from a few weeks to several months. They are inexpensive to produce, readily scalable for mass production, and offer a wide range of clinical applications.
Under terms of the acquisition, the Sustained Release, Inc. Board will be expanded to three with Broadleaf having the exclusive and ongoing right to name two Directors. Donna Steward and Charles Snipe will act as interim Sustained Release Directors until their replacements can be impaneled.
In a related development, Broadleaf is releasing a private placement memorandum (PPM) today to raise $6,000,000 for Sustained Release Inc. contracts and operations. The PPM offers 12,000,000 shares of BDLF Class A Preferred stock at $0.50 per share. Qualifying BDLF Common shareholders will be eligible for a 15% discount on the PPM.
About Broadleaf Capital Partners:
Broadleaf Capital Partners Inc. Inc. (OTC:BDLF) actively identifies and reviews unique and proprietary technologies for investment consideration. Broadleaf seeks such technologies held by emerging or early stage, small to medium-size companies in various fields of business to arrange for capital and provide management support. Our goal is to provide our stockholders capital appreciation and a solid dividend yield.
Learn more about Broadleaf at: http://www.bdlfpartners.com/
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "expects," "intends," "anticipates," "will," or "plans" to be uncertain and forward looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the company's reports and registration statements filed with the Securities and Exchange Commission.
Contacts
Princeton Research, Inc., Las Vegas
Mike King, 702-650-3000
[email protected]
Broadleaf Capital Partners Inc., Las Vegas